Skip to main content

Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001831363

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2023

Institutional positions in Terns Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
93
−10 vs. Q2 2023
Shares held
61.7M
+3.99M (+6.9%) vs. Q2 2023
Total value
$310.4M
−$194.6M (−38.5%) vs. Q2 2023
New holders
10
32 more added
Sold out
20
38 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 93 institutions
Q1 2021: 42 institutionsQ2 2021: 36 institutionsQ3 2021: 34 institutionsQ4 2021: 37 institutionsQ1 2022: 44 institutionsQ2 2022: 42 institutionsQ3 2022: 45 institutionsQ4 2022: 65 institutionsQ1 2023: 79 institutionsQ2 2023: 103 institutionsQ3 2023: 93 institutionsQ4 2023: 103 institutionsQ1 2024: 112 institutionsQ2 2024: 126 institutionsQ3 2024: 156 institutionsQ4 2024: 157 institutionsQ1 2025: 138 institutionsQ2 2025: 130 institutionsQ3 2025: 141 institutionsQ4 2025: 248 institutionsQ1 2026: 317 institutionsQ2 2026: 1 institution
Value heldQ3 2023: $310.4M
Q1 2021: $393.7MQ2 2021: $203.8MQ3 2021: $174.3MQ4 2021: $116.7MQ1 2022: $50.0MQ2 2022: $36.5MQ3 2022: $178.1MQ4 2022: $506.2MQ1 2023: $630.2MQ2 2023: $505.0MQ3 2023: $310.4MQ4 2023: $412.7MQ1 2024: $414.8MQ2 2024: $446.7MQ3 2024: $663.1MQ4 2024: $477.2MQ1 2025: $229.4MQ2 2025: $310.0MQ3 2025: $665.7MQ4 2025: $4.95BQ1 2026: $6.56BQ2 2026: $75.4K
Institutions holding TERN and their total value by quarter
QuarterHoldersValue
Q2 20261$75.4K
Q1 2026317$6.56B
Q4 2025248$4.95B
Q3 2025141$665.7M
Q2 2025130$310.0M
Q1 2025138$229.4M
Q4 2024157$477.2M
Q3 2024156$663.1M
Q2 2024126$446.7M
Q1 2024112$414.8M
Q4 2023103$412.7M
Q3 202393$310.4M
Q2 2023103$505.0M
Q1 202379$630.2M
Q4 202265$506.2M
Q3 202245$178.1M
Q2 202242$36.5M
Q1 202244$50.0M
Q4 202137$116.7M
Q3 202134$174.3M
Q2 202136$203.8M
Q1 202142$393.7M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q2 2023.

Institutions holding TERN in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
State of Wisconsin Investment Board0$00.00%−36,464−100.0%Sold out
Jane Street Group, LLC0$00.00%−24,178−100.0%Sold out
Verition Fund Management LLC0$00.00%−20,500−100.0%Sold out
Squarepoint Ops LLC0$00.00%−15,871−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−12,101−100.0%Sold out
Crosspoint Financial, LLC0$00.00%−12,054−100.0%Sold out
Alpine Global Management, LLC0$00.00%−10,655−100.0%Sold out
Tucker Asset Management LLC0$00.00%−2,824−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−2,400−100.0%Sold out
Impact Partnership Wealth, LLC0$00.00%−227−100.0%Sold out
Federated Hermes, Inc.0$00.00%−168−100.0%Sold out
ICA Group Wealth Management, LLC0$00.00%−60−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−24−100.0%Sold out